Frerichs, K A, Broekmans, M E C, Marin Soto, J A, van Kessel, B, Heymans, M W, Holthof, L C, Verkleij, C P M, Boominathan, R, Vaidya, B, Sendecki, J, Axel, A, Gaudet, F, Pillarisetti, K, Zweegman, S, Adams, H C, Mutis, T, van de Donk, N W C J & van de Donk, N W C J 2020, ' Preclinical Activity of JNJ-7957, a Novel BCMA ×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 26, no. 9, pp. 2203-2215 . https://doi.org/10.1158/1078-0432.CCR-19-2299 Clinical cancer research : an official journal of the American Association for Cancer Research, 26(9), 2203-2215. American Association for Cancer Research Inc.
Chari, A, Minnema, M C, Berdeja, J G, Oriol, A, van de Donk, N W C J, Rodríguez-Otero, P, Askari, E, Mateos, M-V, Costa, L J, Caers, J, Verona, R, Girgis, S, Yang, S, Goldsmith, R B, Yao, X, Pillarisetti, K, Hilder, B W, Russell, J, Goldberg, J D & Krishnan, A 2022, ' Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma ', The New England journal of medicine, vol. 387, no. 24, pp. 2232-2244 . https://doi.org/10.1056/NEJMoa2204591 The New England journal of medicine, 387(24), 2232-2244. Massachussetts Medical Society